2seventy bio (NASDAQ:TSVT) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(1.61) by 62.73 percent. This is a 76.47 percent increase over losses of $(2.55) per share from the same period last year. The company reported quarterly sales of $56.18 million which beat the analyst consensus estimate of $15.52 million by 261.97 percent. This is a 250.38 percent increase over sales of $16.03 million the same period last year.
Here’s What’s Happening To Oil As Debt Ceiling Crisis Drags On
Oil is on track to register first weekly gains in over a month as market participants remain optimistic…
